Skip to main content

Peer Review reports

From: Efficacy of lorlatinib after alectinib-induced interstitial lung disease in a patient with anaplastic lymphoma kinase-positive non-small cell lung cancer: a case report

Original Submission
25 Jun 2021 Submitted Original manuscript
7 Jun 2022 Reviewed Reviewer Report - Teodora Alexa - Stratulat
9 Jun 2022 Reviewed Reviewer Report - Walid AL ACHKAR
29 Jun 2022 Author responded Author comments - Fumihiro Kashizaki
Resubmission - Version 2
29 Jun 2022 Submitted Manuscript version 2
19 Jul 2022 Reviewed Reviewer Report - Teodora Alexa - Stratulat
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
2 Aug 2022 Editorially accepted
24 Aug 2022 Article published 10.1186/s13256-022-03556-8

You can find further information about peer review here.

Back to article page